首页 | 本学科首页   官方微博 | 高级检索  
检索        

川芎嗪对先天性心脏病肺动脉高压体外循环下血栓素A2及前列环素的影响
引用本文:黄瑞健,廖崇先,陈道中,陈为民,翁钦永.川芎嗪对先天性心脏病肺动脉高压体外循环下血栓素A2及前列环素的影响[J].中国中西医结合杂志,1998,18(6):333-335.
作者姓名:黄瑞健  廖崇先  陈道中  陈为民  翁钦永
作者单位:福建医科大学附属第一医院心外科
摘    要:目的:探讨川芎嗪对先天性心脏病肺动脉高压患者全体上血栓素A2(TXA2)/前列环素(PGI2)平衡的保护作用。方法:将30例非紫绀型先天性心脏病肺动脉高压患者随机分为对照组(15例)和用药组(15例)。川芎嗪分别于麻醉诱导后静脉滴注3mg/kg及转流后加入氧合器中1mg/kg,分别于麻醉诱导后、转流15min、升主动脉开放5min、停机后20min、6h及24h采血并测定TXA2、PGI2。结果:

关 键 词:川芎嗪  体外循环  血栓素A2  前列环素  肺动脉高压

Effects in Tetramethylpyrazine on TXA2 and PGI2 by Cardio Pulmonary Bypass in Congenital Heart Diseases with Pulmonary Hypertension Patients
Institution:Huang Ruijian, Liao Chongxian, Chen Daozhong, et al Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou (350005;Huang Ruijian, Liao Chongxian, Chen Daozhong, et al Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou (350005;Huang Ruijian, Liao Chongxian, Chen Daozhong, et al Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou (350005;Huang Ruijian, Liao Chongxian, Chen Daozhong, et al Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou (350005;Huang Ruijian, Liao Chongxian, Chen Daozhong, et al Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou (350005
Abstract:Objective: To study protective effects of tetramethylpyrazine (TMP) on the imbalance of TXA 2/PGI 2 during cardiopulmomary bypass (CPB) in congenital heart disease (CHD) with pulmonary hypertension (PH) patients. Methods: Thirty patients suffered from non cyanotic CHD PH were randomly divided into control group (n=15) and treatment group (n=15). 3 mg/kg of TMP was dripped intravenously after anesthesia and 1 mg/kg of TMP was infused into oxygenator after CPB individually. Blood samples were collected and TXA 2 as well as PGI 2 were measured after anesthesia induction, 15 min during CPB, 5 min after release of the aortic cross clamp,and 20 min, 6 hrs and 24 hrs after CPB. Results: There was significant difference between treatment group and control group except before operation and 24 hrs after CPB. Conclusions: The imbalance of TXA 2 and PGI 2 in patients with CHD PH during CPB could correct by TMP.
Keywords:tetramethylpyrazine  cardiopulmonary bypass  thromboxane A  2  prostacyclin pulmonary hypertension
本文献已被 维普 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号